
www.prnewswire.com/news-releases/volcano-announces-final-results-of-advise-ii-registry-prospectively-demonstrating-performance-and-utility-of-ifr-modality1-to-measure-and-document-severity-of-intermediate-coronary-blockages-229939191.html
Preview meta tags from the www.prnewswire.com website.
Linked Hostnames
18- 321 links towww.prnewswire.com
- 4 links towww.cision.com
- 2 links toportal.prnewswire.com
- 2 links towww.facebook.com
- 1 link to10.86.178.122
- 1 link toapp.prnewswire.com
- 1 link toclinicaltrials.gov
- 1 link togdpr.cision.com
Search Engine Appearance
https://www.prnewswire.com/news-releases/volcano-announces-final-results-of-advise-ii-registry-prospectively-demonstrating-performance-and-utility-of-ifr-modality1-to-measure-and-document-severity-of-intermediate-coronary-blockages-229939191.html
Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages
/PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and...
Bing
Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages
https://www.prnewswire.com/news-releases/volcano-announces-final-results-of-advise-ii-registry-prospectively-demonstrating-performance-and-utility-of-ifr-modality1-to-measure-and-document-severity-of-intermediate-coronary-blockages-229939191.html
/PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and...
DuckDuckGo

Volcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages
/PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and...
General Meta Tags
22- titleVolcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages
- charsetutf-8
- X-UA-CompatibleIE=edge,chrome=1
- viewportwidth=device-width, initial-scale=1
- adobeLaunchScript//assets.adobedtm.com/launch-ENb957f6e7383d4549b191e1190ed5476e.min
Open Graph Meta Tags
4- og:titleVolcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages
- og:typearticles
- og:description/PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and...
- og:urlhttps://www.prnewswire.com/news-releases/volcano-announces-final-results-of-advise-ii-registry-prospectively-demonstrating-performance-and-utility-of-ifr-modality1-to-measure-and-document-severity-of-intermediate-coronary-blockages-229939191.html
Twitter Meta Tags
4- twitter:cardsummary_large_image
- twitter:site@PRNewswire
- twitter:titleVolcano Announces Final Results of ADVISE II Registry, Prospectively Demonstrating Performance and Utility of iFR® Modality[1] to Measure and Document Severity of Intermediate Coronary Blockages
- twitter:description/PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and...
Item Prop Meta Tags
3- description/PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and...
- inLanguageen-US
- keywordsVolcano Corporation
Link Tags
5- canonicalhttps://www.prnewswire.com/news-releases/volcano-announces-final-results-of-advise-ii-registry-prospectively-demonstrating-performance-and-utility-of-ifr-modality1-to-measure-and-document-severity-of-intermediate-coronary-blockages-229939191.html
- icon/content/dam/prnewswire/icons/2019-Q4-PRN-Icon-32-32.png
- icon/content/dam/prnewswire/icons/2019-Q4-PRN-Icon-32-32.png
- stylesheet/etc.clientlibs/prncom/clientlibs/newspage-clientlibs.min.css
- stylesheet/etc.clientlibs/prncom/components/content/prnWidgetButton/clientlib.min.css
Links
343- http://10.86.178.122:2011/Users/jbergan/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/HZIBCIQ3/[email protected]
- http://clinicaltrials.gov/ct2/show/NCT01740895?term=ADVISE+II&rank=1
- https://app.prnewswire.com/login/auto
- https://gdpr.cision.com
- https://portal.prnewswire.com